May 15, 2026
Cargo-free LNP Manufacturing Could Spark a Nucleic Acid Therapy Renaissance
Combining pre-formed vesicles with nucleic acid cargo at the point of care can remove long-standing barriers to personalized nucleic acid therapeutics.
Combining pre-formed vesicles with nucleic acid cargo at the point of care can remove long-standing barriers to personalized nucleic acid therapeutics.